M. De Smet

1.5k total citations
39 papers, 1.0k citations indexed

About

M. De Smet is a scholar working on Molecular Biology, Spectroscopy and Analytical Chemistry. According to data from OpenAlex, M. De Smet has authored 39 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Spectroscopy and 7 papers in Analytical Chemistry. Recurrent topics in M. De Smet's work include Analytical Chemistry and Chromatography (7 papers), Analytical Methods in Pharmaceuticals (6 papers) and Cancer Treatment and Pharmacology (4 papers). M. De Smet is often cited by papers focused on Analytical Chemistry and Chromatography (7 papers), Analytical Methods in Pharmaceuticals (6 papers) and Cancer Treatment and Pharmacology (4 papers). M. De Smet collaborates with scholars based in Belgium, United States and Netherlands. M. De Smet's co-authors include D.L. Massart, Ludo Diels, Philippe Corbisier, S.J.P. Van Belle, Guy Storme, Joop van Gerven, Rik C. Schoemaker, Sanne Lysbet de Haas, M. Gail Murphy and A. Carides and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Antimicrobial Agents and Chemotherapy.

In The Last Decade

M. De Smet

36 papers receiving 973 citations

Peers

M. De Smet
R. Don Brown United States
Carole Bye United Kingdom
P. A. Toseland United Kingdom
John G. Page United States
M. De Smet
Citations per year, relative to M. De Smet M. De Smet (= 1×) peers Hervé Millart

Countries citing papers authored by M. De Smet

Since Specialization
Citations

This map shows the geographic impact of M. De Smet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. De Smet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. De Smet more than expected).

Fields of papers citing papers by M. De Smet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. De Smet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. De Smet. The network helps show where M. De Smet may publish in the future.

Co-authorship network of co-authors of M. De Smet

This figure shows the co-authorship network connecting the top 25 collaborators of M. De Smet. A scholar is included among the top collaborators of M. De Smet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. De Smet. M. De Smet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smet, M. De & Andreas Weiermann. (2010). Sharp Thresholds for a Phase Transition Related to Weakly Increasing Sequences. Journal of Logic and Computation. 22(2). 207–211. 1 indexed citations
2.
Boot, J. D., Sanne Lysbet de Haas, Joop van Gerven, et al.. (2008). MK-0873, a PDE4 inhibitor, does not influence the pharmacokinetics of theophylline in healthy male volunteers. Pulmonary Pharmacology & Therapeutics. 21(3). 573–577. 8 indexed citations
3.
Iwamoto, Marian, Martine E. Laethem, M. De Smet, et al.. (2007). Safety, Tolerability, and Pharmacokinetics of Raltegravir After Single and Multiple Doses in Healthy Subjects. Clinical Pharmacology & Therapeutics. 83(2). 293–299. 134 indexed citations
4.
Cocquyt, V., Simon Van Belle, Robert Reinhardt, et al.. (2001). Comparison of L-758,298, a prodrug for the selective neurokinin-1 antagonist, L-754,030, with ondansetron for the prevention of cisplatin-induced emesis. European Journal of Cancer. 37(7). 835–842. 116 indexed citations
5.
Fisher, Alison L., Thomas L. Shih, Ralph A. Stearns, et al.. (2001). Liquid chromatographic-tandem mass spectrometric urine assay for a highly metabolized cyclic ureidobenzenesulfonamide: issues concerning assay specificity and quality control preparation. Journal of Pharmaceutical and Biomedical Analysis. 26(5-6). 739–752. 14 indexed citations
6.
Diels, Ludo, et al.. (1999). Heavy Metals Bioremediation of Soil. Molecular Biotechnology. 12(2). 149–158. 84 indexed citations
7.
Haarst, Aernout D. van, Joop van Gerven, Adam F. Cohen, et al.. (1999). The effects of moclobemide on the pharmacokinetics of the 5‐HT1B/1D agonist rizatriptan in healthy volunteers. British Journal of Clinical Pharmacology. 48(2). 190–196. 28 indexed citations
8.
Smet, M. De, et al.. (1998). Influence of the selective cyclooxygenase-2 inhibitor, MK-0966 [MK], on digoxin [DG] serum concentrations. Naunyn-Schmiedeberg s Archives of Pharmacology. 358(1). 1 indexed citations
9.
Belle, Simon Van, et al.. (1993). Determination of leucovorin and 5-fluorouracil in plasma by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 612(1). 77–85. 15 indexed citations
10.
Belle, S.J.P. Van, et al.. (1992). High-performance liquid chromatographic determination of navelbine in MO4 mouse fibrosarcoma cells and biological fluids. Journal of Chromatography B Biomedical Sciences and Applications. 576(2). 351–357. 14 indexed citations
11.
Belle, S.J.P. Van, et al.. (1992). Determination of vinca alkaloids in mouse tissues by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 578(2). 223–229. 18 indexed citations
12.
Sanda, Marie, Eric S. Groves, Rubens Belfort, et al.. (1992). Intravenous administration of recombinant human macrophage colony-stimulating factor to patients with metastatic cancer: a phase I study.. Journal of Clinical Oncology. 10(10). 1643–1649. 18 indexed citations
13.
Legius, Eric, et al.. (1989). Rickets due to dietary calcium deficiency. European Journal of Pediatrics. 148(8). 784–785. 33 indexed citations
14.
Smet, M. De & D.L. Massart. (1989). High-performance liquid chromatography of basic drugs on cyanopropyl-bonded phases: Practical aspects. TrAC Trends in Analytical Chemistry. 8(3). 96–101. 6 indexed citations
15.
Smet, M. De & D.L. Massart. (1988). Determination of amiodarone and desethylamiodarone in plasma with a standardised extraction and chromatographic optimisation procedure. Journal of Pharmaceutical and Biomedical Analysis. 6(3). 277–284. 11 indexed citations
16.
Smet, M. De, et al.. (1988). Expert system for the selection of high-performance liquid chromatographic methods in pharmaceutical analysis. Journal of Chromatography A. 457. 25–42. 37 indexed citations
17.
Smet, M. De & D.L. Massart. (1987). Retention behaviour of acidic, neutral and basic drugs on a CN column using phosphate buffers in the mobile phase. Journal of Chromatography A. 410(1). 77–94. 23 indexed citations
18.
Smet, M. De, et al.. (1987). Determination of vinblastine in MO4 mouse fibrosarcoma cells by high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 416(2). 375–381. 12 indexed citations
19.
Smet, M. De & D.L. Massart. (1987). Automated method selection for HPLC analysis of drugs. TrAC Trends in Analytical Chemistry. 6(10). 266–271. 5 indexed citations
20.
Smet, M. De & M. De Visscher. (1960). [Contribution to the study of goiter endemia among the Ueles (Congo Republic)].. PubMed. 40. 601–22. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026